3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is growing attracting clinical scrutiny due to initial evidence suggesting distinct physiological actions. Preliminary analyses suggest that 3-HPC may possess distinct responses on the nervous system, arguably influencing to some of the unexpected manifestations associated with PC